反映肾脏浓缩稀释功能的最佳指标——血、尿渗透量

介绍渗透量的临床应用及其与尿比重的对比     

Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study

Patients on cyclosporin A (CsA) often develop hyperuricaemiaand gout. In transplant patients the use of uricosuric drugsfor treating hyperuricaemia may be preferable to allopurinolbecause of the known interaction of the latter with azathioprine.We therefore prospectively studied the uricosuric efficacy of100 mg benzbromarone (Bbr;Desuric®) daily in 25 CsA-treatedrenal transplant patients with stable graft function and hyperuricaemia(>359 µmol/l for females, >491 µmol/l formales). Benzbromarone decreased plasma uric acid from 579±18µmol/l to 313±24 µmol/l (mean±SEM;P<0.001) and thereby normalized plasma uric acid in 21 of25 patients. The remaining four patients had creatininc clearancesbetween 21 and 25 ml/min, the lowest of the entire study group.Mean fractional clearance of uric acid increased from 5.4±0.4%to 17.2±1.0% (P<0.001). The relative decrease of plasmauric acid closely correlated with baseline creatinine clearance(r=0.67; P<0.001). CsA trough values were not influenced.None of the patients experienced any significant side-effects.As an unexpected find-ing, urinary uric acid excretion increasedfrom 2082 ± 175 µmol7sol;24 h to 3233 ±232µmol/24 h after 4 weeks' treatment with benzbromarone. In conclusion, benzbromarone normalized plasma uric acid inall CsA-treated renal transplant recipients with a creatinineclearance >25 ml/min. Due to its excellent efficacy and lackof significant side-effects, benzbromarone appears to be preferableto allopurinol in CsA-treated renal transplant recipients witha creati nine clearance over 25 ml/min.     

急性原发性痛风性关节炎漏诊分析

本文对15例急性原发性痛风性关节炎进行了回顾性的分析。急性原发性痛风性关节炎常被误诊为多种疾病,其中误诊为类风湿性关节炎、风湿性关节炎者多见。     

孕妇血浆尿酸正常值及其在妊娠高血压综合征的诊断价值

测定了133名正常孕妇和133名妊高征患者的血浆尿酸,其平均值分别为324.00μmol/L和388.91μmol/L,有显著性差异,且尿酸增高程度与病情轻重有关,但两组尿酸分布大部分重叠。确定了孕妇血浆尿酸的95％正常值上限为445μmol/L,在此基础上评价了尿酸对妊高征的诊断价值,认为血浆尿酸只适合用于判断妊高征病情严重程度,不宜用于妊高征的诊断和鉴别诊断。     

血清尿酸水平与冠心病及其危险因子关系的研究

目的:探讨血清尿酸(UA)水平与冠心病(CHD)及其相关因素关系。方法:选择经冠状动脉造影检查证实的冠心病患者187例,冠脉造影正常对照组71例,常规空腹采集静脉血测定血清UA,分析冠心病危险因子、冠状动脉病变程度、病变支数及病变类型与相应UA水平的关系。结果:CHD组的一般资料与对照组无明显差异,但血清UA水平明显高于对照组(P<0.01);在CHD组中,轻度狭窄、中度狭窄及重度狭窄,其UA水平逐渐增高,分别为(418.92±36.52),(450.84±48.65),(487.40±51.62)μmol/L(P<0.01);单支病变、双支病变和三支病变,其UA水平也增高,分别为(426.32±30.78),(455.24±35.34),(480.40±40.12)μmol/L(P<0.01);A、B和C型病变,其UA水平依次增高,分别为(425.85±35.71),(461.65±46.50),(493.41±53.24)μmol/L(P<0.01);结论:血清UA水平的增高与冠心病密切相关,是冠心病发病的危险因素。     

精浆尿酸的检测及其与精液参数的相关性研究

目的：建立精浆尿酸（UA）的检测方法并探讨精浆UA水平与精液参数的相关性。方法：根据检测血清UA的方法加以改良建立检测精浆UA的方法,并观察批内变异和不同技术人员检测结果之间的差异以评价方法的可接受性。同时分析138例男性精浆UA水平与患者年龄、禁欲时间、精液量、pH、精子密度、活动率、a＋b级精子百分率和正常形态精子百分率之间的相关性。结果：精浆UA检测方法的批内变异为9.16%,2位技术人员的检测结果没有显著性差异（P=0.541）。精浆UA水平与正常形态精子百分率呈正相关（r=0.350,P=0.025）,与精子活动率和a＋b级精子百分率有呈正相关的趋势（r=0.147和0.156,P=0.085和0.068）,而与精液分析其他参数如精液量、pH、精子密度、禁欲时间以及患者年龄等无相关性。结论：通过对血清UA检测方法加以改良可以建立可接受的精浆UA检测方法。精子形态学、活动率及a＋b级精子百分率可能与精浆UA水平高低有关。     

男性不育患者精浆尿酸的检测及临床意义初探

目的 :检测男性不育患者精浆尿酸的含量 ,并探讨其与不育的关系。　方法 :2 0 0 3年 2～ 8月就诊的男性不育患者 1 6 3例 ,分为 4组 :梗阻性无精子症组 ,1 5例 ;非梗阻性无精子症组 ,36例 ;少精子症组 ,4 3例 ;弱精子症组 ,6 9例。 2 0例正常生育男性为正常对照组。上述各组均作精液参数分析及精浆尿酸含量的测定。　结果 :正常对照组精浆尿酸含量为 (396 .9± 5 3.1 ) μmol/L ,显著高于梗阻性无精子症组 [(79.5± 1 8.1 ) μmol/L]、非梗阻性无精子症组[(2 4 5 .8± 76 .5 ) μmol/L]、少精子症组 [(2 6 2 .2± 79.2 ) μmol/L]和弱精子症组 [(2 5 1 .4± 75 .4 ) μmol/L](P均 <0 .0 1 )。其中 ,梗阻性无精子症组精浆尿酸含量又显著低于其他各不育症组 (P均 <0 .0 1 ) ,其余各不育症组间精浆尿酸含量差异无显著性 (P >0 .0 5 )。　结论 :精浆中尿酸作为生殖系统中的一种重要抗氧化物 ,可能在男性生殖中具有一定意义。     

The effect of high-intensity training on purine metabolism in man

The effect of intermittent high-intensity training on the activity of enzymes involved in purine metabolism and on the concentration of plasma purines following acute short-term intense exercise was investigated. Eleven subjects performed sprint training three times per week for 6 weeks. Muscle biopsies for determination of enzyme activities were obtained prior to and 24 h after the training period. After training, the activity of adenosine 5′-phosphate (AMP) deaminase was lower (P < 0.001) whereas the activities of hypoxanthine phosphoribosyl transferase (HPRT) and phosphofructokinase were significantly higher compared with pre-training levels. The higher activity of HPRT with training suggests an improved potential for rephosphorylation of intracellular hypoxanthine to inosine monophosphate (IMP) in the trained muscle. Before and after the training period the subjects performed four independent 2-min tests at intensities from a mean of 106 to 135 % of Vo_max. Venous blood was drawn prior to and after each test. The accumulation of plasma hypoxanthine following the four tests was lower following training compared with prior to training (P < 0.05). The accumulation of uric acid was significantly lower (46% of pre-training value) after the test performed at 135% of Fo_2mM (P < 0.05). Based on the observed alterations in muscle enzyme activities and plasma purine accumulation, it is suggested that high intensity intermittent training leads to a lower release of purines from muscle to plasma following intense exercise and, thus, a reduced loss of muscle nucleotides.     

Purine nucleoside phosphorylase deficiency: a new case report and identification of two novel mutations (Gly156A1a and Val217Ile), only one of which (Gly156A1a) is deleterious

Purine nucleoside phosphorylase (PNP) deficiency results in an autosomal recessive immunodeficiency disease characterized by initial involvement of cellular immunity and neurological manifestations with subsequent abnormalities of humoral immunity. The initial presentation and clinical course has varied widely in the relatively few published cases. The molecular basis has been reported in only 10 patients, precluding evaluation of phenotype-genotype relationships. We now report clinical, immunologic, and molecular findings in a new case of relatively early onset that emphasizes hypotonia and developmental delay as early manifestations. The patient carried two novel missense mutations (Gly56A1a and Val217Ile) on the same allele in apparent homozygosity. Expression of each of the mutant enzymes in vitro demonstrated that the Gly156A1a mutation abolished enzyme activity while the Val217Ile mutation was without obvious effect and is therefore a normal variant. Such "normal" polymorphisms might be associated with a variable response to the immunosuppressive PNP inhibitors currently in clinical trials.